Clinical characteristics and outcomes of primary sclerosing cholangitis and ulcerative colitis in Japanese patients
Open accessThe DOI matches its Crossref record; 42 of the 42 references it cites were found in a registry or an index.
Abstract
BACKGROUND: In Western countries, most patients with primary sclerosing cholangitis (PSC) have concurrent ulcerative colitis (UC). The number of patients with UC in East Asia has increased markedly over the past two decades. However, current clinical features of PSC and of PSC associated with UC (PSC-UC) have not yet been clarified in East Asia, particularly in Japan. We aimed to reveal the clinical courses and associations with UC in Japanese patients with PSC from the mutual viewpoint of PSC and UC. METHODS: We retrospectively retrieved medical records of patients with PSC (69) and UC (1242) who were diagnosed at Chiba University Hospital between June 1991 and August 2017. RESULTS: In the present cohort, 37 patients had PSC-UC; the cumulative risks of PSC in patients with UC and of UC in patients with PSC were 3.0% and 53.6%, respectively. We confirmed similar distinctive results by a Japanese nationwide survey, noting that younger patients with PSC had a notably high possibility of association with UC. From the viewpoint of the UC cohort, the occurrence of right-sided disease was significantly higher in patients with PSC-UC than in those with UC (16.2% vs. 4.2%, P = 0.003). Pancolitis was more commonly observed in PSC-UC, and proctits/left-sided colitis was less commonly found in patients with UC. The number of patients with young-onset PSC-UC may be increasing similar to an increase in patients with UC in Japan. CONCLUSIONS: In our cohort, the comorbidity rate of PSC-UC was higher than that obtained in previous reports. The incidence of PSC-UC and UC may increase in the future in East Asia, particularly in Japan.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures




Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The prevalence of IBD in PSC has been estimated to be 50-85% with the highest prevalence in Northern Europe (around 80%).349,350”
From EASL Clinical Practice Guidelines on sclerosing cholangitis (2022) · cites this paper as [350]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Ng, S. C., Shi, H. Y., Hamidi, N., Underwood, F. E., Tang, W., Benchimol, E. I., Panaccione, R., Ghosh, S., Wu, J. C. Y., Chan, F. K. L., et al. (2017) · The Lancet · doi:10.1016/s0140-6736(17)32448-0 · Cited by 6,087
Molodecky, N. A., Soon, I. S., Rabi, D. M., Ghali, W. A., Ferris, M., Chernoff, G., Benchimol, E. I., Panaccione, R., Ghosh, S., Barkema, H. W., et al. (2012) · Gastroenterology · doi:10.1053/j.gastro.2011.10.001 · Cited by 4,833
Magro, F., Gionchetti, P., Eliakim, R., Ardizzone, S., Armuzzi, A., Barreiro-de Acosta, M., Burisch, J., Gecse, K. B., Hart, A. L., Hindryckx, P., et al. (2017) · Journal of Crohn's and Colitis · doi:10.1093/ecco-jcc/jjx008 · Cited by 1,910
Simplified criteria for the diagnosis of autoimmune hepatitis
Hennes, E. M., Zeniya, M., Czaja, A. J., Parés, A., Dalekos, G. N., Krawitt, E. L., Bittencourt, P. L., Porta, G., Boberg, K. M., Hofer, H., et al. (2008) · Hepatology · doi:10.1002/hep.22322 · Cited by 1,901
Diagnosis and Management of Primary Sclerosing Cholangitis
Chapman, R., Fevery, J., Kalloo, A., Nagorney, D. M., Boberg, K. M., Shneider, B., & Gores, G. J. (2010) · Hepatology · doi:10.1002/hep.23294 · Cited by 1,224
Understanding and Preventing the Global Increase of Inflammatory Bowel Disease
Kaplan, G. G., & Ng, S. C. (2017) · Gastroenterology · doi:10.1053/j.gastro.2016.10.020 · Cited by 1,224
EASL Clinical Practice Guidelines: Liver transplantation
(2016) · Journal of Hepatology · doi:10.1016/j.jhep.2015.10.006 · Cited by 1,082
PSC-IBD: a unique form of inflammatory bowel disease associated with primary sclerosing cholangitis
Loftus, E. V., Harewood, G. C., Loftus, C. G., Tremaine, W. J., Harmsen, W. S., Zinsmeister, A. R., Jewell, D. A., & Sandborn, W. J. (2005) · Gut · doi:10.1136/gut.2004.046615 · Cited by 777
Boonstra, K., Weersma, R. K., van Erpecum, K. J., Rauws, E. A., Spanier, B. W. M., Poen, A. C., van Nieuwkerk, K. M., Drenth, J. P., Witteman, B. J., Tuynman, H. A., et al. (2013) · Hepatology · doi:10.1002/hep.26565 · Cited by 725
Ng, S. C., Shi, H. Y., Hamidi, N., Underwood, F. E., Tang, W., Benchimol, E. I., Wu, J. C., Chan, F. K., Sung, J. J., & Kaplan, G. (2017) · Gastroenterology · doi:10.1016/s0016-5085(17)33292-4 · Cited by 675
Epidemiology of primary sclerosing cholangitis and primary biliary cirrhosis: A systematic review
Boonstra, K., Beuers, U., & Ponsioen, C. Y. (2012) · Journal of Hepatology · doi:10.1016/j.jhep.2011.10.025 · Cited by 632
Soetikno, R. M., Lin, O. S., Heidenreich, P. A., Young, H. S., & Blackstone, M. O. (2002) · Gastrointestinal Endoscopy · doi:10.1067/mge.2002.125367 · Cited by 623
Primary sclerosing cholangitis
Hirschfield, G. M., Karlsen, T. H., Lindor, K. D., & Adams, D. H. (2013) · The Lancet · doi:10.1016/s0140-6736(13)60096-3 · Cited by 592
An Update on the Epidemiology of Inflammatory Bowel Disease in Asia
Thia, K. T., Loftus, Jr., Sandborn, W. J., & Yang, S.-K. (2008) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2008.02158.x · Cited by 548
Weismüller, T. J., Trivedi, P. J., Bergquist, A., Imam, M., Lenzen, H., Ponsioen, C. Y., Holm, K., Gotthardt, D., Färkkilä, M. A., Marschall, H.-U., et al. (2017) · Gastroenterology · doi:10.1053/j.gastro.2017.02.038 · Cited by 533
ACG clinical guideline: primary sclerosing cholangitis
Lindor, K. D., Kowdley, K. V., & Harrison, E. M. (2015) · American Journal of Gastroenterology · doi:10.1038/ajg.2015.112 · Cited by 524
Ng, S. C., Tang, W., Leong, R. W., Chen, M., Ko, Y., Studd, C., Niewiadomski, O., Bell, S., Kamm, M. A., de Silva, H. J., et al. (2015) · Gut · doi:10.1136/gutjnl-2014-307410 · Cited by 443
Tischendorf, J. J. W., Hecker, H., Krüger, M., Manns, M. P., & Meier, P. N. (2007) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2006.00872.x · Cited by 413
Ludwig, J., Barham, S. S., Larusso, N. F., Elveback, L. R., Wiesner, R. H., & McCall, J. T. (1981) · Hepatology · doi:10.1002/hep.1840010612 · Cited by 328
Incidence of primary sclerosing cholangitis: A systematic review and meta-analysis
Molodecky, N. A., Kareemi, H., Parab, R., Barkema, H. W., Quan, H., Myers, R. P., & Kaplan, G. G. (2011) · Hepatology · doi:10.1002/hep.24247 · Cited by 273
Aabakken, L., Karlsen, T., Albert, J., Arvanitakis, M., Chazouilleres, O., Dumonceau, J.-M., Färkkilä, M., Fickert, P., Hirschfield, G., Laghi, A., et al. (2017) · Endoscopy · doi:10.1055/s-0043-107029 · Cited by 255
Lunder, A. K., Hov, J. R., Borthne, A., Gleditsch, J., Johannesen, G., Tveit, K., Viktil, E., Henriksen, M., Hovde, Ø., Huppertz-Hauss, G., et al. (2016) · Gastroenterology · doi:10.1053/j.gastro.2016.06.021 · Cited by 212
Patients with small duct primary sclerosing cholangitis have a favourable long term prognosis
Björnsson, E., Boberg, K. M., Cullen, S., Fleming, K., Clausen, O. P., Fausa, O., Schrumpf, E., & Chapman, R. W. (2002) · Gut · doi:10.1136/gut.51.5.731 · Cited by 207
Incidence and prevalence of primary sclerosing cholangitis in a defined adult population in sweden†
Lindkvist, B., Benito de Valle, M., Gullberg, B., & Björnsson, E. (2010) · Hepatology · doi:10.1002/hep.23678 · Cited by 206
Joo, M., Abreu-e-Lima, P., Farraye, F., Smith, T., Swaroop, P., Gardner, L., Lauwers, G. Y., & Odze, R. D. (2009) · American Journal of Surgical Pathology · doi:10.1097/pas.0b013e318196d018 · Cited by 184
Primary sclerosing cholangitis in Japan?analysis of 192 cases
Takikawa, H., & Manabe, T. (1997) · Journal of Gastroenterology · doi:10.1007/bf01213311 · Cited by 123
Gulamhusein, A. F., Eaton, J. E., Tabibian, J. H., Atkinson, E. J., Juran, B. D., & Lazaridis, K. N. (2016) · American Journal of Gastroenterology · doi:10.1038/ajg.2016.55 · Cited by 116
Marelli, L., Xirouchakis, E., Kalambokis, G., Cholongitas, E., Hamilton, M. I., & Burroughs, A. K. (2011) · Gut · doi:10.1136/gut.2010.235408 · Cited by 113
Japanese herbal medicine Inchin-ko-to as a therapeutic drug for liver fibrosis
Inao, M., Mochida, S., Matsui, A., Eguchi, Y., Yulutuz, Y., Wang, Y., Naiki, K., Kakinuma, T., Fujimori, K., Nagoshi, S., et al. (2004) · Journal of Hepatology · doi:10.1016/j.jhep.2004.06.033 · Cited by 112
Aabakken, L., Karlsen, T. H., Albert, J., Arvanitakis, M., Chazouilleres, O., Dumonceau, J.-M., Färkkilä, M., Fickert, P., Hirschfield, G. M., Laghi, A., et al. (2017) · Journal of Hepatology · doi:10.1016/j.jhep.2017.02.013 · Cited by 107
Sano, H., Nakazawa, T., Ando, T., Hayashi, K., Naitoh, I., Okumura, F., Miyabe, K., Yoshida, M., Takahashi, S., Ohara, H., et al. (2011) · Journal of Hepato-Biliary-Pancreatic Sciences · doi:10.1007/s00534-010-0319-8 · Cited by 103
Sørensen, J. Ø., Nielsen, O. H., Andersson, M., Ainsworth, M. A., Ytting, H., Bélard, E., & Jess, T. (2018) · Liver International · doi:10.1111/liv.13548 · Cited by 84
Henriksen, E. K. K., Jørgensen, K. K., Kaveh, F., Holm, K., Hamm, D., Olweus, J., Melum, E., Chung, B. K., Eide, T. J., Lundin, K. E. A., et al. (2017) · Journal of Hepatology · doi:10.1016/j.jhep.2016.09.002 · Cited by 82
Nordenvall, C., Olén, O., Nilsson, P. J., von Seth, E., Ekbom, A., Bottai, M., Myrelid, P., & Bergquist, A. (2018) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.14393 · Cited by 78
Ye, B. D., Yang, S.-K., Boo, S.-J., Cho, Y. K., Yang, D.-H., Yoon, S. M., Kim, K. J., Byeon, J.-S., Myung, S.-J., Yu, C. S., et al. (2011) · Inflammatory Bowel Diseases · doi:10.1002/ibd.21569 · Cited by 75
Prospective study of bezafibrate for the treatment of primary sclerosing cholangitis
Mizuno, S., Hirano, K., Isayama, H., Watanabe, T., Yamamoto, N., Nakai, Y., Sasahira, N., Tada, M., Omata, M., & Koike, K. (2015) · Journal of Hepato-Biliary-Pancreatic Sciences · doi:10.1002/jhbp.281 · Cited by 61
Yang, Y., Owyang, C., & Wu, G. D. (2016) · Gastroenterology · doi:10.1053/j.gastro.2016.10.034 · Cited by 54
Navaneethan, U., Venkatesh, P. G. K., Lashner, B. A., Shen, B., & Kiran, R. P. (2012) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2012.05063.x · Cited by 43
Tanaka, A., Tazuma, S., Nakazawa, T., Isayama, H., Tsuyuguchi, T., Inui, K., & Takikawa, H. (2017) · Journal of Hepato-Biliary-Pancreatic Sciences · doi:10.1002/jhbp.432 · Cited by 37
Self-citationNavaneethan, U., Venkatesh, P. G. K., Jegadeesan, R., Lourdusamy, V., Hammel, J., Kiran, R. P., & Shen, B. (2014) · Gastroenterology report · doi:10.1093/gastro/gou074 · Cited by 28
Clinical profiles of patients with primary sclerosing cholangitis in the elderly
Tanaka, A., Tazuma, S., Okazaki, K., Tsubouchi, H., Inui, K., & Takikawa, H. (2015) · Journal of Hepato-Biliary-Pancreatic Sciences · doi:10.1002/jhbp.194 · Cited by 23
Ulcerative colitis -recent advance in clinical practice and basic research.
Matsuoka, K., & Watanabe, M. (2016) · PubMed · doi:10.11405/nisshoshi.113.407 · Cited by 8
Cited by
EASL Clinical Practice Guidelines on sclerosing cholangitis
Chazouilleres, O., Beuers, U., Bergquist, A., Karlsen, T. H., Levy, C., Samyn, M., Schramm, C., & Trauner, M. (2022) · Journal of Hepatology · doi:10.1016/j.jhep.2022.05.011 · Cited by 419
Park, C. H., Park, S. W., Yang, M. J., Moon, S., & Park, D. H. (2021) · Surgical Endoscopy · doi:10.1007/s00464-021-08491-1 · Cited by 45
Antigen-Specific Immunotherapy for Treatment of Autoimmune Liver Diseases
Richardson, N., Ng, S. T. H., & Wraith, D. C. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.01586 · Cited by 40
“Up to 80% of PSC patients also present with inflammatory bowel disease (IBD), indicating a general gastrointestinal inflammatory phenotype (93).”
BackgroundAttauabi, M., Zhao, M., Bendtsen, F., & Burisch, J. M. (2020) · Inflammatory Bowel Diseases · doi:10.1093/ibd/izaa167 · Cited by 32
de Souza, M. H. G., Lima, L. C. V., Al‐Sharif, L., & Huang, D. Q. (2024) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2024.09.037 · Cited by 22
Metadata
- Authors
- Kumagai, J., Taida, T., Ogasawara, S., Nakagawa, T., Iino, Y., Shingyoji, A., Ishikawa, K., Akizue, N., Yamato, M., Takahashi, K., Ohta, Y., Hamanaka, S., Okimoto, K., Nakamura, M., Ohyama, H., Saito, K., Kusakabe, Y., Maruoka, D., Yasui, S., Matsumura, T., Sugiyama, H., Sakai, Y., Mikata, R., Arai, M., Katsuno, T., Tsuyuguchi, T., & Kato, N.
- Affiliations
- Chiba University (JP)
- Corresponding author
- Tsuyuguchi, Toshio
- ORCID
- Taida, Takashi
- Ogasawara, Sadahisa
- Nakagawa, Tomoo
- Iino, Yotaro
- Akizue, Naoki
- Takahashi, Koji
- Ohta, Yuki
- Okimoto, Kenichiro
- Nakamura, Masato
- Ohyama, Hiroshi
- Kusakabe, Yuko
- Maruoka, Daisuke
- Yasui, Shin
- Matsumura, Tomoaki
- Sugiyama, Harutoshi
- Sakai, Yuji
- Mikata, Rintaro
- Arai, Makoto
- Katsuno, Tatsuro
- Tsuyuguchi, Toshio
- Kato, Naoya
- Venue
- PLOS ONE
- Publisher
- Public Library of Science (PLoS)
- Published
- 2018-12-20
- Volume
- 13
- Issue
- 12
- Pages
- e0209352
- ISSN
- 1932-6203 (ISSN-L)
- PMC
- PMC6301618
- OpenAlex
- W2905635517
- Cited by
- 29
- References
- 42
- Citations by year
- 2026: 1 · 2025: 1 · 2024: 3 · 2023: 4 · 2022: 5 · 2021: 8 · 2020: 7
- FWCI
- 2.35
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- PLoS ONE (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Figshare (submittedVersion, cc-by)
- Funders
- Daiichi-Sankyo
- Topics
- Health Sciences › Medicine › Hepatology › Liver Diseases and Immunity
- Health Sciences › Medicine › Gastroenterology › Inflammatory Bowel Disease
- Health Sciences › Medicine › Ophthalmology › Ocular Diseases and Behçet’s Syndrome
- Keywords
- primary sclerosing cholangitis, ulcerative colitis, comorbidities, clinical features, right-sided colitis, pancolitis, disease incidence, Japanese patients
- MeSH terms
- Adolescent, Adult, Age Factors, Aged, Child, Child, Preschool, Colitis, Ulcerative, Female, Humans, Japan, Male, Middle Aged, Retrospective Studies, Cholangitis, Sclerosing, Comorbidity, Incidence, Age of Onset, Young Adult
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.